510(k) Report

510(k) · Cleared

Cleared

IQ Body Fluids Control

K051706510(k) TraditionalCleared Aug 17, 200551-day reviewClass II21 CFR 864.8625

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Streck · JPK Mixture, Hematology Quality Control

Cleared on Aug 17, 2005 as substantially equivalent to K000076 (Streck Laboratories, Inc., 2000) after a 51-day review. Its family tree reaches back 1 generation to 2000. 6 later devices descend from it.

Decided
Aug 17, 2005
Review
51 days
Class
Class II
Product code
JPK
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K000076 (2000). 6 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2006: 1 descendant cleared2009: 1 descendant cleared2012: 1 descendant cleared2011: 1 descendant cleared2014: 1 descendant cleared2016: 1 descendant clearedK000076 · Cell-Chex · Streck Laboratories, Inc. · 2000200020052010201520202025
Descendants, by generation 1 generation forward: 1 descendant2 generations forward: 3 descendants3 generations forward: 1 descendant4 generations forward: 1 descendant K000076 · Cell-Chex · Streck Laboratories, Inc. · 20000
  1. Root · 1 generation backK000076 Cell-ChexStreck Laboratories, Inc. · 2000
  2. This deviceK051706 IQ Body Fluids ControlStreck · 2005
  3. Descendant · cites it directly · 5 of its ownK053362 Cell-Chex AutoStreck · 2006
  4. Descendant · 2 generations on · 2 of its ownK120744 XN Check BFStreck · 2012
  5. Descendant · 3 generations on · 1 of its ownK141957 XN Check BFStreck · 2014
  6. Descendant · 4 generations on · 0 of its ownK160588 XN Check BFStreck · 2016
  7. Descendant · 2 generations on · 0 of its ownK101578 R&D Systems Body Fluid-I Hematology ControlR&D Systems, Inc. · 2011

Showing 5 of 6 descendants. See all descendants

Descendants cleared per year

2006: 12009: 12011: 12012: 12014: 12016: 1
2006high 1 (2006) · low 0 (2007)2026

Most influential descendants

Showing 5 of 6 · See all
  • K053362Cell-Chex AutoStreck · 2006 · cites it directly5descendants
  • K120744XN Check BFStreck · 2012 · 2 generations on2descendants
  • K141957XN Check BFStreck · 2014 · 3 generations on1descendant
  • K160588XN Check BFStreck · 2016 · 4 generations on0descendants
  • K101578R&D Systems Body Fluid-I Hematology ControlR&D Systems, Inc. · 2011 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K000076Cell-ChexStreck Laboratories, Inc.2000—
0 (this device)K051706IQ Body Fluids ControlStreck2005—
+1K053362Cell-Chex AutoStreck2006—
+2K120744XN Check BFStreck2012—
+3K141957XN Check BFStreck2014—
+4K160588XN Check BFStreck2016—
+2K101578R&D Systems Body Fluid-I Hematology ControlR&D Systems, Inc.2011—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200610
200910
201110
201210
201410
201610
FIG. 1 — Lineage of K051706, 2000–2016Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JPK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K000076Cell-Chex
Summary page 1
…Hematology Control for Body Fluids Classification Name: White and Red Blood Cell Control (864.8625) Predicate Device: Cell-Chex (K000076) Manufactured by Streck Description: 0Q Body Fluids Control is a stabilized suspension of human red blood cells and simulated w…
Streck Laboratories, Inc.2000—

Also cleared against K000076: 2 other devices →

What descends from it? (6)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K053362Cell-Chex AutoStreck20065

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K053362 (Streck, 2006) has gone furthest, with 5 descendants of its own.
  • 2 other devices also cite its predicate K000076.

How does its category compare?

All JPK devices

JPK Mixture, Hematology Quality Control: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JPK

4in 2016

2007: 52009: 52010: 42011: 12012: 22013: 12014: 22016: 4
2007high 5 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JPK

296in 2016

2007: 44 days median2009: 187 days median2010: 267 days median2016: 296 days median
2007high 296 (2016) · low 44 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JPK

1in 2022

2007: 12010: 22011: 32012: 12020: 12021: 22022: 1
2007high 3 (2011) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JPK

2in 2023

2007: 142008: 12010: 52011: 562012: 22014: 12019: 12020: 12021: 12023: 2
2007high 56 (2011) · low 0 (2009)2025

MAUDE reports naming product code JPK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007544114
20080—01
2009518700
2010426725
20111—356
20122—12
20131—00
20142—01
20150—00
2016429600
20170—00
20180—00
20190—01
20200—11
20210—21
20220—10
20230—02
20240—00
20250—00
20260—0—

What is it indicated for?

iQ® Body Fluids Controls are intended for use on iQ® Series analyzers, with the optional iQ® Body Fluids Module installed, as a control for evaluating body fluid RBC and nucleated cell counts. The device will consist of two levels of red blood cells and nucleated cells.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K051706: IQ Body Fluids Control.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K051706

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026